Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

205.11 +0.80 (+0.39%)

Streaming Delayed Price Updated: 10:12 AM EDT, Apr 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Insulet (NASDAQ:PODD) Beats Expectations in Strong Q2, Stock Soars

August 07, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 32.9% year on year to $649.1 million. On top of that, next quarter’s...

Via StockStory

Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5 ↗

August 07, 2025

Insulet beats Q2 estimates with strong Omnipod growth and lifts 2025 revenue outlook on rising adoption and expanding global customer base.

Via Benzinga

Exploring the top movers within the S&P500 index during today's session. ↗

August 07, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Applovin, Sunrun, Duolingo, Tutor Perini, Installed Building Products And Other Big Stocks Moving Higher On Thursday ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Thursday's session: gap up and gap down stock in the S&P500 index ↗

August 07, 2025

Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.

Via Chartmill

Insulet (PODD) Q2 Revenue Jumps 33% ↗

August 07, 2025

Via The Motley Fool

Insulet Pops As Diabetes Medtech Continues Its Streak Of 'Impressive Beat-And-Raises' ↗

August 07, 2025

The company is still in the early stages of adding patients with type 2 diabetes to its client base.

Via Investor's Business Daily

Insulet Corp. (NASDAQ:PODD) Delivers Strong Q2 2025 Earnings, Surpassing Revenue and EPS Forecasts ↗

August 07, 2025

Insulet Corp. (PODD) reported strong Q2 2025 earnings, beating revenue and EPS estimates with $649.1M in sales and $1.17 adjusted EPS. Stock rose 4.58% pre-market. Raised full-year guidance signals...

Via Chartmill

Looking Into Insulet's Recent Short Interest ↗

July 22, 2025

Via Benzinga

These S&P500 stocks are moving in today's pre-market session ↗

August 07, 2025

Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday?

Via Chartmill

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

August 07, 2025

From Insulet Corporation

Via Business Wire

Insulet (PODD) Q2 Earnings: What To Expect

August 05, 2025

Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Thursday before the bell. Here’s what you need to know.

Via StockStory

Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years ↗

August 01, 2025

Via Benzinga

Senator Mullin Discloses Stock Trades 2.5 Years After They Were Made, Including One Up 134.5% ↗

August 01, 2025

Via Benzinga

$1000 Invested In Insulet 10 Years Ago Would Be Worth This Much Today ↗

July 17, 2025

Via Benzinga

1 Healthcare Stock on Our Buy List and 2 to Brush Off

July 15, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the...

Via StockStory

Topics Stocks

How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes ↗

July 14, 2025

An update on Sana Biotechnology.

Via Benzinga

2 High-Flying Stocks to Target This Week and 1 to Avoid

July 11, 2025

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly...

Via StockStory

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

July 08, 2025

From Insulet Corporation

Via Business Wire

2 Mid-Cap Stocks Worth Your Attention and 1 to Brush Off

July 04, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

Topics Supply Chain

3 Growth Stocks to Stash

July 03, 2025

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Via StockStory

Topics Artificial Intelligence

Stay informed with the top movers within the S&P500 index on Tuesday. ↗

July 01, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids ↗

July 01, 2025

A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process.

Via Investor's Business Daily

Tesla, Progress Software, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 01, 2025

Via Benzinga

These S&P500 stocks are moving in today's pre-market session ↗

July 01, 2025

Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today ↗

June 30, 2025

Via Benzinga

10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential ↗

June 28, 2025

Via The Motley Fool

Topics Artificial Intelligence

INSULET CORP (NASDAQ:PODD) – A Strong Growth Stock with Technical Breakout Potential ↗

June 24, 2025

INSULET CORP (NASDAQ:PODD) shows strong revenue growth, high profitability, and a bullish technical setup, making it a noteworthy candidate for growth investors.

Via Chartmill

Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod® 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions

June 19, 2025

From Insulet Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.